Are you looking for an innovative company that guides you in the development of your molecule from the early stages?
For over 25 years, Oncodesign has been developingtechnology platforms to support translational research from the early stages of the Drug Discovery process - a real driver of innovation acceleration and success for your molecule.
Mike Brown - Sales Manager - will be there to listen to you and find out about our offerings in oncology, immunology, dermatology, inflammatory and infectious diseases.
Discover our expertise on the exclusive MS2Plex offering presented in the poster below:
[POSTER] « Quantitative Targeted Absolute Proteomics (QTAP) analysis of transporters for the validation of an in vitro Blood Brain Barrier model”